Skip to content

A multicenter cohort study on cerebral amyloid angiopathy in China

A multicenter cohort study on cerebral amyloid angiopathy in China

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2500096664
Enrollment
Unknown
Registered
2025-01-27
Start date
2025-01-28
Completion date
Unknown
Last updated
2025-02-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cerebral amyloid angiopathy

Interventions

Probable and possible CAA group:None
Pathologically supported inclusion criteria for CAA group:None
CAA-RI group:None
ARIA group:None

Sponsors

Tianjin Huanhu Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to No maximum

Inclusion criteria

Inclusion criteria: 1.Probable and possible CAA inclusion criteria: a.>=50 years old, gender unlimited; b. meeting the 2022 Boston 2.0 diagnostic criteria is probable and possible CAA; c. cooperate with the completion of head MRI examination; d. sign the informed consent form. 2.Pathologically supported inclusion criteria for CAA patients were as follows: a. patients with lobular hemorrhage after brain tissue removal of hematoma; b. patients with probable CAA who meet the 2022 Boston 2.0 diagnostic criteria for pathological support; c. cooperating with the completion of head MRI examination; d. sign the informed consent for surgery.

Exclusion criteria

Exclusion criteria: Exclusion criteria: a. complicated with serious diseases such as liver and kidney, heart and lung, blood system, and malignant tumors; b. Patients with other diseases of the nervous system (such as intracranial space occupation, intracranial infection, massive cerebral infarction, etc.); c. Examine patients who are uncooperative or refuse to participate;

Design outcomes

Primary

MeasureTime frame
Neuropsychological scale score;

Secondary

MeasureTime frame
Plasma biomarker;APOE genotypes;Head MRI;Pathological results of brain tissue;

Countries

China

Contacts

Public ContactYong Ji

Tianjin Huanhu Hospital

jiyongusa@126.com+86 13612048681

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026